Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Medtronic
MDT
|
$464M |
| 2 |
Exxon Mobil
XOM
|
$299M |
| 3 |
FedEx
FDX
|
$289M |
| 4 |
Netflix
NFLX
|
$273M |
| 5 |
Micron Technology
MU
|
$265M |
Top Sells
| 1 |
Amazon
AMZN
|
$290M |
| 2 |
Electronic Arts
EA
|
$285M |
| 3 |
Mastercard
MA
|
$269M |
| 4 |
RAI
Reynolds American Inc
RAI
|
$245M |
| 5 |
Johnson & Johnson
JNJ
|
$237M |
Sector Composition
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.39% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.47% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Humana
HUM
$36.5B
| $892M | 1.05% | 3,660,100 +929,000 | +34% | +$226M |
|
2
Gilead Sciences
GILD
$140B
| $829M | 0.98% | 10,230,899 -176,949 | -2% | -$14.3M |
|
3
Amgen
AMGN
$155B
| $730M | 0.86% | 3,917,700 +517,555 | +15% | +$96.5M |
|
4
NVIDIA
NVDA
$4.24T
| $717M | 0.84% | 4,010,100 -748,693 | -16% | -$134M |
|
5
NetEase
NTES
$86.2B
| $708M | 0.83% | 2,683,050 -42,950 | -2% | -$11.3M |
|
6
Colgate-Palmolive
CL
$67.9B
| $700M | 0.82% | 9,604,100 -149,300 | -2% | -$10.9M |
|
7
Novo Nordisk
NVO
$251B
| $691M | 0.81% | 14,361,300 +827,000 | +6% | +$39.8M |
|
8
Bristol-Myers Squibb
BMY
$96B
| $691M | 0.81% | 10,846,600 -2,641,600 | -20% | -$168M |
|
9
Domino's
DPZ
$15.6B
| $640M | 0.75% | 3,222,300 +161,400 | +5% | +$32M |
|
10
VeriSign
VRSN
$25.5B
| $629M | 0.74% | 5,909,776 +864,300 | +17% | +$92M |
|
11
PepsiCo
PEP
$204B
| $613M | 0.72% | 5,500,700 -142,000 | -3% | -$15.8M |
|
|
12
Johnson & Johnson
JNJ
$427B
| $560M | 0.66% | 4,306,200 -1,826,000 | -30% | -$237M |
|
13
Palo Alto Networks
PANW
$127B
| $533M | 0.63% | 3,697,900 +1,550,600 | +72% | +$223M |
|
|
14
Medtronic
MDT
$119B
| $498M | 0.59% | 6,397,513 +5,963,513 | +1,374% | +$464M |
|
15
Crown Castle
CCI
$43.2B
| $491M | 0.58% | 4,914,000 +38,497 | +0.8% | +$3.85M |
|
16
Cboe Global Markets
CBOE
$24.7B
| $472M | 0.56% | 4,389,700 +19,704 | +0.5% | +$2.12M |
|
17
Walmart
WMT
$774B
| $472M | 0.56% | 6,043,000 +979,900 | +19% | +$76.6M |
|
|
BCR
18
DELISTED
CR Bard Inc.
BCR
| $455M | 0.54% | 1,418,500 +122,900 | +9% | +$39.4M |
|
19
Intuitive Surgical
ISRG
$170B
| $448M | 0.53% | 428,600 +121,500 | +40% | +$127M |
|
20
Home Depot
HD
$405B
| $434M | 0.51% | 2,652,800 +773,400 | +41% | +$126M |
|
|
21
Netflix
NFLX
$513B
| $385M | 0.45% | 2,123,600 +1,504,300 | +243% | +$273M |
|
22
GSK
GSK
$79.9B
| $383M | 0.45% | 9,437,700 +99,700 | +1% | +$4.05M |
|
23
Align Technology
ALGN
$10.3B
| $379M | 0.45% | 2,037,200 +449,519 | +28% | +$83.7M |
|
24
Chubb
CB
$110B
| $371M | 0.44% | 2,600,761 +196,300 | +8% | +$28M |
|
|
25
Mastercard
MA
$538B
| $353M | 0.42% | 2,500,100 -1,903,800 | -43% | -$269M |
|